← back to search

Stephan Seitz

University Hospital Regensburg · DE
Area of research
Oncology · Surgery
Research interest
Research interests include Breast Implant and Reconstruction, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, and HER2/EGFR in Cancer Research.
h-index
19
citations
863
works
90
NIH funding
primary concept
email

Recent publications

Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients
BMC Medicine 2026cited by 1position: middledoi
Additional file 1 of Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients
Open MIND 2026cited by 0position: middledoi
Additional file 1 of Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients
Figshare 2026cited by 0position: middledoi
Treatment Regimens and Response Rates in Early TNBC: A Review of Real‐World Practice in the Second Decade of the 21st Century
The Breast Journal 2026cited by 0position: lastdoi
Chemotherapy in elderly patients with early breast cancer: a systematic review
Archives of Gynecology and Obstetrics 2025cited by 2position: middledoi
Breast cancer scoring based on a multiplexed profiling of soluble and cell-associated (immune) markers facilitates the prediction of pembrolizumab therapy
Cancer Cell International 2025cited by 2position: middledoi
Evaluation of Baseline Characteristics and Therapeutic Management Strategies in Metastatic Cervical Cancer in Germany: A Multicentric Retrospective Longitudinal Observational Study
Geburtshilfe und Frauenheilkunde 2025cited by 2position: middledoi
Hereditäre Krebserkrankungen in der Gynäkologie
Die Gynäkologie 2025cited by 0position: firstdoi
App-based support for breast cancer patients to reduce psychological distress during therapy and survivorship – a multicentric randomized controlled trial
Frontiers in Oncology 2024cited by 19position: middledoi
Clinical impact of delaying initiation of adjuvant chemotherapy in patients with early triple negative breast cancer
Breast Cancer Research and Treatment 2024cited by 11position: lastdoi
HER4 Affects Sensitivity to Tamoxifen and Abemaciclib in Luminal Breast Cancer Cells and Restricts Tumor Growth in MCF-7-Based Humanized Tumor Mice
International Journal of Molecular Sciences 2024cited by 7position: middledoi
Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patients
Molecular Oncology 2024cited by 1position: middledoi
Abstract 3788: EpCAM+ DCCs isolated from the bone marrow of breast cancer patients display high stemness and potency scores
Cancer Research 2024cited by 0position: middledoi
Abstract 4124: Patient-derived ex vivo models to test drug responses of disseminated cancer cells in various metastatic niches
Cancer Research 2024cited by 0position: middledoi
Abstract 3708: Characterization of EpCAM-positive cells for specific detection of disseminated cancer cells in bone marrow of early breast cancer patients
Cancer Research 2024cited by 0position: middledoi
Abstract PS04-01: Clinical impact of timing of systemic therapy in patients with early triple negative breast cancer
Cancer Research 2024cited by 0position: lastdoi
Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?
Journal of Cancer Research and Clinical Oncology 2023cited by 10position: lastdoi
Lightweight implants in breast reconstruction
Clinical Hemorheology and Microcirculation 2023cited by 3position: middledoi
Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?
Research Square 2023cited by 2position: lastdoi
Untersuchungsmethoden in der Gynäkologie und Geburtshilfe
2023cited by 0position: middledoi
Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre
British Journal of Cancer 2022cited by 29position: middledoi
The effect of radiotherapy on fat engraftment for complete breast reconstruction using lipofilling only
Archives of Gynecology and Obstetrics 2022cited by 13position: middledoi
Implants Versus Lipograft: Analysis of Long-Term Results Following Congenital Breast Asymmetry Correction
Aesthetic Plastic Surgery 2022cited by 9position: middledoi
Surgery of congenital breast asymmetry-which objective parameter influences the subjective satisfaction with long-term results
Archives of Gynecology and Obstetrics 2022cited by 4position: middledoi
Autologous fat grafting for breast reconstruction after breast cancer: a 12-year experience
Archives of Gynecology and Obstetrics 2021cited by 31position: middledoi
Surgery of congenital breast asymmetry—which objective parameter influences the subjective satisfaction with long-term results
Archives of Gynecology and Obstetrics 2021cited by 12position: middledoi
<i>STRN-ALK</i>Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy
JCO Precision Oncology 2021cited by 9position: lastdoi
Correction to: New aspects in digital breast assessment: further refinement of a method for automated digital anthropometry
Archives of Gynecology and Obstetrics 2021cited by 3position: middledoi
Implants versus Lipograft – Analysis of Long-Term Results after Congenital Breast Asymmetry Procedure
Preprints.org 2021cited by 2position: middledoi
“Surgery of Congenital Breast Asymmetry – Which Objective Parameter Influences the Subjective Satisfaction With Long-term Results?”
Research Square 2021cited by 2position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Olaf Ortmann · University of Regensburg13 papers (2012–2025)Vanessa Brébant · University of Regensburg11 papers (2020–2023)Lukas Prantl · Technical University of Munich11 papers (2020–2023)Andreas Eigenberger · University of Regensburg10 papers (2020–2023)Maximilian Weiherer · University of Regensburg8 papers (2020–2022)Monika Klinikhammer-Schalke · University of Regensburg7 papers (2014–2026)Vivien Noisser · University of Regensburg7 papers (2020–2022)Florian Weber · University of Oslo7 papers (2012–2025)Maria Eleni Hatzipanagiotou · University of Regensburg6 papers (2023–2026)Stefan Buchholz · Ludwig-Maximilians-Universität München6 papers (2012–2014)Andrew V. Schally · Bruce W. Carter VA Medical Center6 papers (2012–2014)Florian Hohla · Paracelsus Medical University5 papers (2012–2014)Luca Szalontay · Memorial Sloan Kettering Cancer Center5 papers (2012–2014)Michael Gerken · University of Regensburg5 papers (2023–2025)Ferenc G. Rick · Florida International University5 papers (2012–2014)Miriam Pigerl · University of Regensburg5 papers (2023–2026)Sophie Räpple · University of Regensburg5 papers (2023–2026)Elisabeth C. Inwald · University of Regensburg5 papers (2014–2024)Norman L. Block · Orthopedic Specialty Hospital4 papers (2012–2012)Madeleine Hetterich · University of Regensburg4 papers (2023–2024)